vs
Burlington Stores, Inc.（BURL）与爱德华生命科学（EW）财务数据对比。点击上方公司名可切换其他公司
Burlington Stores, Inc.的季度营收约是爱德华生命科学的1.6倍（$2.7B vs $1.6B），爱德华生命科学净利率更高（23.1% vs 3.9%，领先19.2%），爱德华生命科学同比增速更快（16.7% vs 7.1%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -6.9%）
伯灵顿百货（前身为伯灵顿大衣厂）是美国知名全国性折扣零售商，在全美46个州及波多黎各拥有超过1138家门店，总部位于新泽西州伯灵顿镇。2007年公司被贝恩资本收购，2008年汤姆·金斯伯里出任总裁兼首席执行官，2013年重新上市，现为美国第三大折扣零售企业。
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
BURL vs EW — 直观对比
营收规模更大
BURL
是对方的1.6倍
$1.6B
营收增速更快
EW
高出9.6%
7.1%
净利率更高
EW
高出19.2%
3.9%
两年增速更快
EW
近两年复合增速
-6.9%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.7B | $1.6B |
| 净利润 | $104.8M | $380.7M |
| 毛利率 | 44.2% | 78.0% |
| 营业利润率 | 5.1% | 1.8% |
| 净利率 | 3.9% | 23.1% |
| 营收同比 | 7.1% | 16.7% |
| 净利润同比 | 15.6% | 6.8% |
| 每股收益（稀释后） | $1.63 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BURLEW
| Q1 26 | — | $1.6B | ||
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.7B | $1.6B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $3.3B | $1.4B | ||
| Q4 24 | $2.5B | $1.4B | ||
| Q3 24 | $2.5B | $1.4B | ||
| Q2 24 | $2.4B | $1.4B |
净利润BURLEW
| Q1 26 | — | $380.7M | ||
| Q4 25 | $104.8M | $91.2M | ||
| Q3 25 | $94.2M | $291.1M | ||
| Q2 25 | $100.8M | $333.2M | ||
| Q1 25 | $260.8M | $358.0M | ||
| Q4 24 | $90.6M | $385.6M | ||
| Q3 24 | $73.8M | $3.1B | ||
| Q2 24 | $78.5M | $366.3M |
毛利率BURLEW
| Q1 26 | — | 78.0% | ||
| Q4 25 | 44.2% | 78.1% | ||
| Q3 25 | 43.7% | 77.8% | ||
| Q2 25 | 43.8% | 77.5% | ||
| Q1 25 | 42.9% | 78.7% | ||
| Q4 24 | 43.9% | 78.9% | ||
| Q3 24 | 42.8% | 80.6% | ||
| Q2 24 | 43.5% | 79.9% |
营业利润率BURLEW
| Q1 26 | — | 1.8% | ||
| Q4 25 | 5.1% | 9.6% | ||
| Q3 25 | 4.7% | 19.8% | ||
| Q2 25 | 5.3% | 26.8% | ||
| Q1 25 | 10.6% | 27.9% | ||
| Q4 24 | 4.7% | 22.6% | ||
| Q3 24 | 4.0% | 25.9% | ||
| Q2 24 | 4.7% | 26.8% |
净利率BURLEW
| Q1 26 | — | 23.1% | ||
| Q4 25 | 3.9% | 5.8% | ||
| Q3 25 | 3.5% | 18.7% | ||
| Q2 25 | 4.0% | 21.7% | ||
| Q1 25 | 8.0% | 25.3% | ||
| Q4 24 | 3.6% | 27.8% | ||
| Q3 24 | 3.0% | 226.7% | ||
| Q2 24 | 3.3% | 26.7% |
每股收益（稀释后）BURLEW
| Q1 26 | — | $0.66 | ||
| Q4 25 | $1.63 | $0.16 | ||
| Q3 25 | $1.47 | $0.50 | ||
| Q2 25 | $1.58 | $0.56 | ||
| Q1 25 | $4.03 | $0.61 | ||
| Q4 24 | $1.40 | $0.65 | ||
| Q3 24 | $1.15 | $5.13 | ||
| Q2 24 | $1.22 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $584.1M | — |
| 总债务越低越好 | $2.0B | — |
| 股东权益账面价值 | $1.5B | — |
| 总资产 | $9.6B | — |
| 负债/权益比越低杠杆越低 | 1.32× | — |
8季度趋势，按日历期对齐
现金及短期投资BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $584.1M | $4.2B | ||
| Q3 25 | $747.6M | $3.8B | ||
| Q2 25 | $371.1M | $4.1B | ||
| Q1 25 | $994.7M | $3.9B | ||
| Q4 24 | $857.8M | $4.0B | ||
| Q3 24 | $659.9M | $4.4B | ||
| Q2 24 | $742.3M | $2.0B |
总债务BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — |
股东权益BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $10.3B | ||
| Q3 25 | $1.4B | $10.2B | ||
| Q2 25 | $1.4B | $10.5B | ||
| Q1 25 | $1.4B | $10.1B | ||
| Q4 24 | $1.1B | $10.0B | ||
| Q3 24 | $1.1B | $9.5B | ||
| Q2 24 | $1.0B | $7.4B |
总资产BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $9.6B | $13.7B | ||
| Q3 25 | $9.3B | $13.3B | ||
| Q2 25 | $8.5B | $13.5B | ||
| Q1 25 | $8.8B | $13.0B | ||
| Q4 24 | $8.4B | $13.1B | ||
| Q3 24 | $7.8B | $13.0B | ||
| Q2 24 | $7.7B | $10.1B |
负债/权益比BURLEW
| Q1 26 | — | — | ||
| Q4 25 | 1.32× | — | ||
| Q3 25 | 1.40× | — | ||
| Q2 25 | 1.21× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 1.35× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 1.20× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $143.3M | — |
| 自由现金流经营现金流 - 资本支出 | $-109.6M | — |
| 自由现金流率自由现金流/营收 | -4.1% | — |
| 资本支出强度资本支出/营收 | 9.3% | — |
| 现金转化率经营现金流/净利润 | 1.37× | — |
| 过去12个月自由现金流最近4个季度 | $-358.5M | — |
8季度趋势，按日历期对齐
经营现金流BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $143.3M | $450.9M | ||
| Q3 25 | $179.4M | $573.7M | ||
| Q2 25 | $-28.9M | $290.2M | ||
| Q1 25 | $543.2M | $280.4M | ||
| Q4 24 | $110.4M | $-127.5M | ||
| Q3 24 | $160.4M | $351.8M | ||
| Q2 24 | $49.4M | $371.5M |
自由现金流BURLEW
| Q1 26 | — | — | ||
| Q4 25 | $-109.6M | $353.5M | ||
| Q3 25 | $-101.0K | $516.2M | ||
| Q2 25 | $-438.6M | $240.9M | ||
| Q1 25 | $189.8M | $224.4M | ||
| Q4 24 | $-56.2M | $-177.3M | ||
| Q3 24 | $-35.2M | $299.9M | ||
| Q2 24 | $-115.5M | $286.1M |
自由现金流率BURLEW
| Q1 26 | — | — | ||
| Q4 25 | -4.1% | 22.5% | ||
| Q3 25 | -0.0% | 33.2% | ||
| Q2 25 | -17.5% | 15.7% | ||
| Q1 25 | 5.8% | 15.9% | ||
| Q4 24 | -2.2% | -12.8% | ||
| Q3 24 | -1.4% | 22.1% | ||
| Q2 24 | -4.9% | 20.9% |
资本支出强度BURLEW
| Q1 26 | — | — | ||
| Q4 25 | 9.3% | 6.2% | ||
| Q3 25 | 6.6% | 3.7% | ||
| Q2 25 | 16.4% | 3.2% | ||
| Q1 25 | 10.8% | 4.0% | ||
| Q4 24 | 6.6% | 3.6% | ||
| Q3 24 | 7.9% | 3.8% | ||
| Q2 24 | 7.0% | 6.2% |
现金转化率BURLEW
| Q1 26 | — | — | ||
| Q4 25 | 1.37× | 4.94× | ||
| Q3 25 | 1.91× | 1.97× | ||
| Q2 25 | -0.29× | 0.87× | ||
| Q1 25 | 2.08× | 0.78× | ||
| Q4 24 | 1.22× | -0.33× | ||
| Q3 24 | 2.18× | 0.11× | ||
| Q2 24 | 0.63× | 1.01× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
